Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Mary Anne Nemeth"'
Autor:
Michael A, Mont, John A, Carrino, Mary Anne, Nemeth, Aimee, Burr, Takaharu, Yamabe, Lars, Viktrup, Mark T, Brown, Christine R, West, Kenneth M, Verburg
Publikováno v:
Surgical technology international. 38
This prospective cohort study (ClinicalTrials.gov identifier: NCT02674386) evaluated the postoperative outcomes of patients who had undergone total joint replacement (TJR) while participating in one of three tanezumab (a nerve growth factor inhibitor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d3c78a7acfc813650411745f49ca10fc
https://pubmed.ncbi.nlm.nih.gov/34043229
https://pubmed.ncbi.nlm.nih.gov/34043229
Autor:
Mark T. Brown, Christine R. West, Mary Anne Nemeth, Aimee M. Burr, Lars Viktrup, Takaharu Yamabe, John A. Carrino, Kenneth M. Verburg, Michael A. Mont
Publikováno v:
Surgical Technology Online.
Introduction: This prospective cohort study (ClinicalTrials.gov identifier: NCT02674386) evaluated the postoperative outcomes of patients who had undergone total joint replacement (TJR) while participating in one of three tanezumab (a nerve growth fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98b9662c10eb97f7a14a35f95aef3fe2
https://doi.org/10.52198/21.sti.38.os1439
https://doi.org/10.52198/21.sti.38.os1439
Autor:
Christine Alvey, Manisha Lamba, Thomas C. Stock, Mary Anne Nemeth, Andrew Blanchard, Joseph Kushner, Vincent DeMatteo, Ronnie Wang, Raymond Chen
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 147
Purpose To determine if a validated Level A in-vitro in-vivo correlation (IVIVC) could be achieved with the extrudable core system (ECS) osmotic tablet platform. Tofacitinib is an oral JAK inhibitor for the treatment of rheumatoid arthritis. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4078ced05ba95790a18cae5032b9cc22
https://pubmed.ncbi.nlm.nih.gov/31863865
https://pubmed.ncbi.nlm.nih.gov/31863865
Autor:
Mary Anne Nemeth, Lars Viktrup, Mark T. Brown, Michael A. Mont, F. Shafiei, Aimee M. Burr, Christine R. West, Takaharu Yamabe, John A. Carrino, Kenneth M. Verburg
Publikováno v:
Osteoarthritis and Cartilage. 28:S29
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8805283aacb14dddd1162b199fb1119f
https://doi.org/10.1016/j.joca.2020.02.047
https://doi.org/10.1016/j.joca.2020.02.047
Autor:
Mark T. Brown, Alan J. Kivitz, Candace Bramson, Joseph Gimbel, Christine R. West, David Keller, Mary Anne Nemeth, Kenneth M. Verburg
Publikováno v:
Pain. 154:1009-1021
Tanezumab is a humanized monoclonal antibody that specifically inhibits nerve growth factor as a treatment for chronic pain. This phase IIB study investigated the efficacy and safety of tanezumab for chronic low back pain vs placebo and naproxen. Pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27e50da2e5e73cc0b4d128f3fe0edcd4
https://doi.org/10.1016/j.pain.2013.03.006
https://doi.org/10.1016/j.pain.2013.03.006
Autor:
Candace Bramson, Mary Anne Nemeth, David G. Borenstein, Michael D. Smith, C. Birbara, Mark T. Brown, Nathaniel P. Katz
Publikováno v:
Pain. 152:2248-2258
Increased nerve growth factor levels are associated with chronic pain conditions, including chronic low back pain (LBP). This study examined safety and analgesic efficacy of tanezumab, a humanized anti-nerve growth factor antibody, in adults with chr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82710f8b2ea930bf47f8661ce9953ddf
https://doi.org/10.1016/j.pain.2011.05.003
https://doi.org/10.1016/j.pain.2011.05.003
Autor:
Mark T. Brown, Michael D. Smith, Nathaniel P. Katz, David G. Borenstein, Candace Bramson, Mary Anne Nemeth, C. Birbara
Publikováno v:
Pain. 153:1129-1131
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::febfa9368c47db81e1c9a21f1c20420a
https://doi.org/10.1016/j.pain.2012.02.033
https://doi.org/10.1016/j.pain.2012.02.033
Autor:
Mary Anne Nemeth, James M. McCarty, Stan L. Block, Kenneth J. Tack, Constance H. Keyserling, James Hedrick
Publikováno v:
The Pediatric Infectious Disease Journal. 19:S159-S165
Objective. Two dosage regimens of cefdinir were compared with amoxicillin/clavulanate for the treatment of suppurative acute otitis media (AOM) in children. Methods. This was an investigator-blinded, randomized, comparative, multicenter trial, in whi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adc447aa9d071f336a1e94438df455f3
https://doi.org/10.1097/00006454-200012001-00005
https://doi.org/10.1097/00006454-200012001-00005
Autor:
Charles M. Fogarty, Robert B. Bettis, Timothy J. Griffin, Kenneth J. Tack, Constance H. Keyserling, Mary Anne Nemeth
Publikováno v:
Journal of Antimicrobial Chemotherapy. 45:851-858
Patients with acute exacerbations of chronic bronchitis were treated with cefdinir 300 mg bd for 5 days or cefprozil 500 mg bd for 10 days in a prospective, randomized, double-blind, multicentre study. Of the 548 patients enrolled, 281 (51%) were eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1262610f3501f091923a0ecf92b8372a
https://doi.org/10.1093/jac/45.6.851
https://doi.org/10.1093/jac/45.6.851
Autor:
Mary Anne Nemeth, Claus Rudolph, Gerhard Siemon, Kenneth J. Tack, Charles E. Langan, Constance H. Keyserling, C.L.A. Van Herwaarden
Publikováno v:
International Journal of Infectious Diseases. 4:26-33
Objectives: To assess the efficacy and tolerability of three antibiotic regimens in patients with acute exacerbation of chronic bronchitis. Methods: In this double-blind, randomized, multicentered, parallel-group study, patients received once-daily c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eebbe08a6fc1c3a46b757859112914d9
https://doi.org/10.1016/s1201-9712(00)90062-6
https://doi.org/10.1016/s1201-9712(00)90062-6